Melanie Davies, chair of Fertility Preservation UK and BMS medical advisory council member raises concern over a new medical procedure that claims to allow women to delay the onset of the menopause by over a decade.
The British Menopause Society has issued this further update on the current availability of HRT products to provide guidance to BMS members and clinical practitioners in response to the ongoing HRT shortages.
A recent Lancet paper, updating the evidence on the association between hormone replacement therapy (HRT) and the risk of breast cancer made prominent headlines.
Several types of vaginal estrogen are now available and can be extremely helpful for treatment of the effects of menopausal estrogen deficiency on the vagina and bladder.
The British Menopause Society has produced a second series of seven short videos covering different aspects of the menopause.
Long-term influence of estrogen plus progestin and estrogen alone use on breast cancer incidence: The Women’s Health Initiative randomized trials. Chlebowski RT, Anderson GL, Aragaki AK, et al Oral presentation at the San Antonio Breast Cancer Symposium; December 10-14, 2019 San Antonio, Texas Researchers from the Women Health Initiative Randomised Trial (WHI) presented on the [...]
The British Menopause Society has produced this further update on the current availability of HRT products.
A new tool for clinicians, Induced menopause in women with endometriosis, is now available on the BMS website.
The BMS has produced a document in response to the ongoing HRT shortages and to provide guidance to BMS members and clinical practitioners who may be experiencing difficulties with HRT supplies.
Are you passionate about women’s health advocacy? Could you lead the broad range of lay voices that support the Royal College of Obstetricians and Gynaecologists’ work to improve women’s health?